These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9127460)

  • 41. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
    Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
    J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
    Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
    Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis.
    Parviainen MT; Jääskeläinen K; Kröger H; Arnala I; Alhava E
    Clin Chim Acta; 1999 Jan; 279(1-2):145-54. PubMed ID: 10064126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of analytical performance and biological variability of three bone resorption assays.
    Ju HS; Leung S; Brown B; Stringer MA; Leigh S; Scherrer C; Shepard K; Jenkins D; Knudsen J; Cannon R
    Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium.
    Yamaga A; Taga M; Minaguchi H
    Endocr J; 1997 Oct; 44(5):733-8. PubMed ID: 9466331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks.
    Aoshima H; Kushida K; Takahashi M; Ohishi T; Hoshino H; Suzuki M; Inoue T
    Bone; 1998 Jan; 22(1):73-8. PubMed ID: 9437516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical usefulness of urinary CrossLaps as a sensitive marker of bone metabolism.
    Nakayama H; Yano T; Sagara Y; Ando K; Kasai Y; Taketani Y
    Endocr J; 1997 Aug; 44(4):479-84. PubMed ID: 9447279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy.
    Abildgaard N; Brixen K; Kristensen JE; Eriksen EF; Nielsen JL; Heickendorff L
    Br J Haematol; 2003 Jan; 120(2):235-42. PubMed ID: 12542480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of bone resorption markers during hypocalcemia in dairy cows.
    Liesegang A; Sassi ML; Risteli J; Eicher R; Wanner M; Riond JL
    J Dairy Sci; 1998 Oct; 81(10):2614-22. PubMed ID: 9812267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis.
    Sassi ML; Aman S; Hakala M; Luukkainen R; Risteli J
    Clin Chem Lab Med; 2003 Aug; 41(8):1038-44. PubMed ID: 12964811
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
    Brady JD; Ju J; Robins SP
    Clin Sci (Lond); 1999 Feb; 96(2):209-15. PubMed ID: 9918902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Markers of bone turnover in postmenopausal women receiving hormone replacement therapy.
    Hamwi A; Ganem AH; Grebe C; Kerschan-Schindl K; Preisinger E; Boschitsch E; Bieglmayer C
    Clin Chem Lab Med; 2001 May; 39(5):414-7. PubMed ID: 11434391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.
    Lehmann HJ; Mouritzen U; Christgau S; Cloos PA; Christiansen C
    Ann Rheum Dis; 2002 Jun; 61(6):530-3. PubMed ID: 12006327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.